219 related articles for article (PubMed ID: 15050904)
1. Differently cross-linked and uncross-linked carboxy-terminal telopeptides of type I collagen in human mineralised bone.
Eriksen HA; Sharp CA; Robins SP; Sassi ML; Risteli L; Risteli J
Bone; 2004 Apr; 34(4):720-7. PubMed ID: 15050904
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K.
Sassi ML; Eriksen H; Risteli L; Niemi S; Mansell J; Gowen M; Risteli J
Bone; 2000 Apr; 26(4):367-73. PubMed ID: 10719280
[TBL] [Abstract][Full Text] [Related]
3. Heterotrimeric type I collagen C-telopeptide conformation as docked to its helix receptor.
Malone JP; Veis A
Biochemistry; 2004 Dec; 43(49):15358-66. PubMed ID: 15581348
[TBL] [Abstract][Full Text] [Related]
4. Type I collagen N-telopeptides adopt an ordered structure when docked to their helix receptor during fibrillogenesis.
Malone JP; George A; Veis A
Proteins; 2004 Feb; 54(2):206-15. PubMed ID: 14696182
[TBL] [Abstract][Full Text] [Related]
5. Cyanogen bromide peptides of the fibrillar collagens I, III, and V and their mass spectrometric characterization: detection of linear peptides, peptide glycosylation, and cross-linking peptides involved in formation of homo- and heterotypic fibrils.
Henkel W; Dreisewerd K
J Proteome Res; 2007 Nov; 6(11):4269-89. PubMed ID: 17939700
[TBL] [Abstract][Full Text] [Related]
6. Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone.
Hanson DA; Eyre DR
J Biol Chem; 1996 Oct; 271(43):26508-16. PubMed ID: 8900119
[TBL] [Abstract][Full Text] [Related]
7. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
Koivula MK; Aman S; Karjalainen A; Hakala M; Risteli J
Ann Rheum Dis; 2005 Oct; 64(10):1443-50. PubMed ID: 16162901
[TBL] [Abstract][Full Text] [Related]
8. Isoaspartyl bond formation within N-terminal sequences of collagen type I: implications for their use as markers of collagen degradation.
Brady JD; Ju J; Robins SP
Clin Sci (Lond); 1999 Feb; 96(2):209-15. PubMed ID: 9918902
[TBL] [Abstract][Full Text] [Related]
9. Increased content of type III collagen at the rupture site of human Achilles tendon.
Eriksen HA; Pajala A; Leppilahti J; Risteli J
J Orthop Res; 2002 Nov; 20(6):1352-7. PubMed ID: 12472252
[TBL] [Abstract][Full Text] [Related]
10. Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover.
Gineyts E; Cloos PA; Borel O; Grimaud L; Delmas PD; Garnero P
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):481-5. PubMed ID: 10642505
[TBL] [Abstract][Full Text] [Related]
11. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
12. Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo.
Kauppila S; Bode MK; Stenbäck F; Risteli L; Risteli J
Br J Cancer; 1999 Oct; 81(4):654-61. PubMed ID: 10574251
[TBL] [Abstract][Full Text] [Related]
13. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
Garnero P; Schott AM; Prockop D; Chevrel G
Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
[TBL] [Abstract][Full Text] [Related]
14. Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links.
Banse X; Sims TJ; Bailey AJ
J Bone Miner Res; 2002 Sep; 17(9):1621-8. PubMed ID: 12211432
[TBL] [Abstract][Full Text] [Related]
15. Shotgun cross-linking analysis for studying quaternary and tertiary protein structures.
Lee YJ; Lackner LL; Nunnari JM; Phinney BS
J Proteome Res; 2007 Oct; 6(10):3908-17. PubMed ID: 17854217
[TBL] [Abstract][Full Text] [Related]
16. Probing alpha-crystallin structure using chemical cross-linkers and mass spectrometry.
Peterson JJ; Young MM; Takemoto LJ
Mol Vis; 2004 Nov; 10():857-66. PubMed ID: 15570221
[TBL] [Abstract][Full Text] [Related]
17. Lysyl hydroxylase-2b directs collagen cross-linking pathways in MC3T3-E1 cells.
Pornprasertsuk S; Duarte WR; Mochida Y; Yamauchi M
J Bone Miner Res; 2004 Aug; 19(8):1349-55. PubMed ID: 15231023
[TBL] [Abstract][Full Text] [Related]
18. quantitative determination of collagen cross-links.
Avery NC; Sims TJ; Bailey AJ
Methods Mol Biol; 2009; 522():103-21. PubMed ID: 19247601
[TBL] [Abstract][Full Text] [Related]
19. A method of isolating the collagen (I) alpha2 chain carboxytelopeptide for species identification in bone fragments.
Buckley M; Collins M; Thomas-Oates J
Anal Biochem; 2008 Mar; 374(2):325-34. PubMed ID: 18164255
[TBL] [Abstract][Full Text] [Related]
20. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
